Förster, Moritz
Küry, Patrick
Aktas, Orhan
Warnke, Clemens
Havla, Joachim
Hohlfeld, Reinhard
Mares, Jan
Hartung, Hans-Peter http://orcid.org/0000-0002-0614-6989
Kremer, David
Article History
First Online: 3 January 2019
Compliance with Ethical Standards
:
: Moritz Förster, Patrick Küry, and Jan Mares declare that they have no competing interests. Orhan Aktas received grant support from Bayer, Biogen, Novartis, and Sanofi and consultancy or speaking fees from Bayer, Biogen, Novartis, Roche, Sanofi, and Teva. Hans-Peter Hartung received consultancy fees and fees for serving on steering or data monitoring committees and advisory boards from Bayer Healthcare, Biogen, GeNeuro, Genzyme, MedDay, Merck, Novartis, Celgene Receptos, Roche, and Teva. Joachim Havla received grant support for OCT (optical coherence tomography) research from the Friedrich-Baur Foundation in Munich, and personal fees and non-financial support from Merck, Novartis, Roche, Bayer, Biogen, Sanofi, Santhera, and Genzyme. Reinhard Hohlfeld received grant support from Biogen, Genzyme-Sanofi, Merck-Serono, Novartis, and Teva and personal fees from Actelion, Biogen, Genzyme-Sanofi, MedDay, Merck-Serono, Novartis, Roche, and Teva. David Kremer received travel grants from GeNeuro and Merck, refund of congress participation fees from GeNeuro, Merck, and Servier, consulting fees from Grifols, payment for lectures from Grifols, and support for research projects from Teva. Clemens Warnke received support from the Hertie foundation (P1150063) and has received personal fees from Novartis, Bayer, Biogen, and Teva.
: None of the authors received funding for preparation of this manuscript.